top of page
  • Writer's pictureA2A Pharma

Fierce Biotech

Updated: Feb 7, 2020

Insilico and A2A launched new Deuchenne-focused AI drug company


66 views0 comments

Recent Posts

See All

Biomea Fusion, Inc., a precision oncology company dedicated to developing innovative medicines targeting genomically defined alterations in both hematologic and solid cancers, announced the closing of

bottom of page